StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Organic Revenue Growth — Life Sciences Solutions by Year

Organic Revenue Growth — Life Sciences Solutions (%)

Thermo Fisher Scientific Organic Revenue Growth — Life Sciences Solutions: 3.0% in FY2025, up 7.0 pts from a year earlier.

Latest, FY2025
3.0%
Period ended Dec 31, 2025
Change on a year earlier
+7.0 pts
-4.0% in FY2024
History
3 years
Since FY2023
Sources
3
Documents cited below

Where the FY2025 figure comes from

“LSS: Organic revenue growth (non-GAAP measure) 2% 4% 5% 4% 3% 1% 3% 1%”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package (Business Segment Information) & SEC MD&A.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOrganic Revenue Growth — Life Sciences Solutions (%)Year on yearSource
FY2025Dec 31, 20253.0%+7.0 ptsQ3 2026 Reconciliation of Financial Information ↗
FY2024Dec 31, 2024-4.0%+22.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
FY2023Dec 31, 2023-26.0%–Q4 & FY2024 Reconciliation of Financial Information ↗

Breakdown

What makes up organic Revenue Growth — Life Sciences Solutions

Cite this data

StockData. (2026). Thermo Fisher Scientific Organic Revenue Growth — Life Sciences Solutions (%), annual FY2023–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/org-growth-pct-lss

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.